1. Home
  2. PCRX vs AMPS Comparison

PCRX vs AMPS Comparison

Compare PCRX & AMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • AMPS
  • Stock Information
  • Founded
  • PCRX 2006
  • AMPS 2009
  • Country
  • PCRX United States
  • AMPS United States
  • Employees
  • PCRX N/A
  • AMPS N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • AMPS Electric Utilities: Central
  • Sector
  • PCRX Health Care
  • AMPS Utilities
  • Exchange
  • PCRX Nasdaq
  • AMPS Nasdaq
  • Market Cap
  • PCRX 1.2B
  • AMPS 608.0M
  • IPO Year
  • PCRX 2011
  • AMPS N/A
  • Fundamental
  • Price
  • PCRX $26.88
  • AMPS $3.86
  • Analyst Decision
  • PCRX Buy
  • AMPS Strong Buy
  • Analyst Count
  • PCRX 10
  • AMPS 9
  • Target Price
  • PCRX $29.30
  • AMPS $5.38
  • AVG Volume (30 Days)
  • PCRX 892.8K
  • AMPS 1.1M
  • Earning Date
  • PCRX 02-27-2025
  • AMPS 03-13-2025
  • Dividend Yield
  • PCRX N/A
  • AMPS N/A
  • EPS Growth
  • PCRX N/A
  • AMPS N/A
  • EPS
  • PCRX N/A
  • AMPS 0.22
  • Revenue
  • PCRX $694,957,000.00
  • AMPS $185,992,000.00
  • Revenue This Year
  • PCRX $5.14
  • AMPS $30.74
  • Revenue Next Year
  • PCRX $2.44
  • AMPS $17.00
  • P/E Ratio
  • PCRX N/A
  • AMPS $17.86
  • Revenue Growth
  • PCRX 4.40
  • AMPS 25.90
  • 52 Week Low
  • PCRX $11.16
  • AMPS $2.71
  • 52 Week High
  • PCRX $31.67
  • AMPS $7.28
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 77.75
  • AMPS 51.87
  • Support Level
  • PCRX $25.06
  • AMPS $3.80
  • Resistance Level
  • PCRX $27.10
  • AMPS $4.14
  • Average True Range (ATR)
  • PCRX 1.45
  • AMPS 0.23
  • MACD
  • PCRX 0.28
  • AMPS 0.02
  • Stochastic Oscillator
  • PCRX 86.23
  • AMPS 78.82

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About AMPS Altus Power Inc.

Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.

Share on Social Networks: